Effects of a third intensification block of chemotherapy on bone and collagen turnover, insulin-like growth factor I, its binding proteins and short-term growth in children with acute lymphoblastic leukaemia

• Published in: European journal of cancer (1990) 1999-06, Vol.35 (6), p.960-967
• Main Authors: Crofton, P.M, Ahmed, S.F, Wade, J.C, Elmlinger, M.W, Ranke, M.B, Kelnar, C.J.H, Wallace, W.H.B
• Format: Article
• Language: English
• Subjects: acute lymphoblastic leukaemia; Adolescent; alkaline; Antineoplastic Combined Chemotherapy Protocols - metabolism; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Bone Resorption; bone turnover; chemotherapy; Child; Child, Preschool; children; Collagen - metabolism; collagen peptides; Drug toxicity and drugs side effects treatment; Female; growth; Humans; Insulin-Like Growth Factor Binding Protein 1 - metabolism; insulin-like growth factor binding proteins; insulin-like growth factor I; Insulin-Like Growth Factor I - metabolism; Male; Medical sciences; Neoplasm Proteins - metabolism; Pharmacology. Drug treatments; phosphatase; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism; Randomized Controlled Trials as Topic; Toxicity: osteoarticular system
• ISSN: 0959-8049; 1879-0852
• DOI: 10.1016/S0959-8049(99)00060-X

Children with acute lymphoblastic leukaemia (ALL) have reduced bone turnover caused by the disease itself and early intensive chemotherapy, but the effects of later chemotherapy using different drug combinations are uncertain. We report here a longitudinal study on 9 children with ALL randomised to receive an additional third intensification block of chemotherapy, compared with 9 children receiving continuing chemotherapy over the same period. During third intensification, bone alkaline phosphatase, procollagen type I C-terminal propeptide, the carboxyterminal propeptide of type I collagen, procollagen type III N-terminal propeptide and lower leg length all decreased in response to dexamethasone, then returned to (but not beyond) baseline levels after dexamethasone was stopped and other drugs started. These changes were unrelated to circulating insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3 or IGFBP-2. In all children, bone alkaline phosphatase remained below the population mean throughout. We conclude that dexamethasone decreased bone and soft tissue turnover, probably through direct effects on target tissues. The postdexamethasone phase of third intensification and continuing chemotherapy had no major deleterious effect on collagen turnover, but there was evidence of continuing suboptimal bone mineralisation.